PPARG and metabolic syndrome: Altered mutations in PPAR-γ cause a variety of complications leading to insulin resistance, type 2 diabetes, hypertension, increased triglycerides, low high density lipoprotein level, and dyslipidemia [110] which are all clinical manifestations of the metabolic syndrome.